查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2020271

大麻二酚市場規模、佔有率、成長率及全球產業分析：按類型、應用和地區的洞察，2026-2034年的預測

Cannabidiol Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 160 Pages | 商品交期: 請詢問到貨日

價格

大麻二酚（CBD）市場的成長要素

全球大麻二酚（CBD）市場正經歷前所未有的成長，這主要得益於消費者對其健康益處的認知不斷提高、合法化進程的推進以及各行各業應用範圍的擴大。根據 Fortunebusinessinsights.com 最近發布的一份報告顯示，該市場在2025年達到 165.2億美元，預計2026年成長至 246.1億美元，並最終在2034年達到 3820.4億美元，在2026年至2034年達到 3820.4億美元，在2026年至2034年的成長率

市場促進因素與成長要素

CBD主要提取自hemp，因為其天然大麻二酚含量高，但也可以從marijuana中提取。與四氫大麻酚（THC）不同，CBD不具有精神活性作用，並具有多種治療功效，包括緩解焦慮、抗發炎、預防癲癇發作和減輕疼痛。其在製藥、化妝品和食品行業的日益普及，進一步推動了市場需求的激增。

製造商正日益著重開發創新產品，以滿足不斷變化的消費者偏好。例如，2024年2月，British Cannabis收購了Goodbody Botanicals，以拓展其全球CBD保健品和化妝品產品組合。此外，儘管新冠疫情初期因封鎖措施和食品飲料行業的下滑而影響了市場成長，但疫情後的復甦預計將支撐強勁成長。

市場區隔

依原料分類：

預計到2026年，源自marijuana的CBD產品將佔據市場主導地位，佔總市場佔有率的56.07%。這主要得益於北美和歐洲地區大麻產品供應量的增加和合法化進程的推進。源自hemp的CBD產品也迅速發展，尤其是在健康和保健產品領域。

用途：

由於CBD產品具有治療功效，製藥業仍是其最大的消費產業。預計到2026年，製藥業將佔全球市場佔有率的36.9%，在疼痛管理、神經保護和發炎控制方面將有顯著應用。食品飲料產業也擴大在強化型和健康型產品中添加CBD。

區域趨勢

北美：

到2025年，該地區主導全球CBD市場，佔據47.63%的市場佔有率（78.7億美元），預計在2026年達到118億美元。受放鬆管制和消費者接受度提高的推動，美國市場預計到2032年將成長至787.4億美元。加拿大也因監管改革和產品多元化而呈現穩定成長。

歐洲：

到2025年，歐洲佔市場佔有率的25.52%（42.2億美元），預計到2026年將達到 62.8億美元。主要市場包括英國（2026年為 17.6億美元）和德國（2026年為 11.9億美元），這兩個國家對吸食、電子煙和食用 CBD 產品的需求上升。

亞太地區：

亞太市場預計到2025年將達到28.8億美元（佔全球市場佔有率的17.47%），並在2026年成長至42.8億美元，這主要得益於中國、日本、印度和泰國等國的監管政策變化。泰國已將醫用大麻和hemp合法化，使其成為該地區的成長中心。

南美洲、中東和非洲以及拉丁美洲：

在南美洲，由於法律改革，市場擴張，烏拉圭、秘魯和哥倫比亞在醫用大麻合法化方面處於領先地位。中東和非洲市場在2025年達到6.5億美元，但由於阿拉伯聯合大公國和沙烏地阿拉伯的監管政策，成長速度放緩。另一方面，黎巴嫩和南非的市場發展動力良好。拉丁美洲市場在2025年達到9億美元，預計在2026年達到13.2億美元。

主要市場趨勢

1.健康與健身：消費者越來越青睞添加 CBD 的產品，以促進健康、消炎並維持整體健康。2022年 8月，BASF公司推出了 ComfortBD，這是一款獲得有機認證的CBD護膚產品，專門針對泛紅和發炎肌膚。

2.政府核准：監管機構，特別是美國 FDA 的核准，加速 CBD 被納入食品、藥品和其他應用領域。

3.併購：策略性收購，例如 British Cannabis 在2024年收購 Goodbody Botanicals，日益擴大產品系列和市場佔有率。

主要企業

主要CBD公司正致力於產品創新、研發和分銷，以鞏固其市場佔有率。主要公司包括：

  • Medical Marijuana Inc. (California, U.S.)
  • Medterra CBD (California, U.S.)
  • Aurora Cannabis Inc. (Edmonton, Canada)
  • ENDOCA (Chicago, U.S.)
  • Folium Biosciences (Texas, U.S.)

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機會
  • 新興趨勢

第4章 主要考察

  • 大麻市場概覽
  • 供應鏈與產業的SWOT分析
  • 全球大麻二酚監管分析
  • 近期產業趨勢：政策、併購、新產品發布
  • 新冠疫情的影響
    • 供應鏈面臨的挑戰
    • 為緩解這些挑戰所做的努力

第5章 2021-2034年全球大麻二酚市場分析、洞察與預測

  • 主要發現與總結
  • 市場規模估算與預測
    • 來源
      • marijuana
      • hemp
    • 依用途
      • 食品/飲料
      • 藥品
      • 寵物護理
      • 化妝品
      • 其他
    • 依地區
      • 北美洲
      • 歐洲
      • 亞太地區
      • 南美洲
      • 中東和非洲

第6章 北美大麻二酚市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章 歐洲大麻二酚市場分析、洞察與預測（2021-2034年）

  • 國家
    • 俄羅斯
    • 奧地利
    • 義大利
    • 德國
    • 英國
    • 其他歐洲國家

第8章 2021-2034年亞太地區大麻二酚市場分析、洞察與預測

  • 國家
    • 中國
    • 澳洲
    • 印度
    • 日本
    • 其他亞太國家

第9章 2021-2034年南美洲大麻二酚市場分析、洞察與預測

  • 國家
    • 阿根廷
    • 巴西
    • 其他南美國家

第10章 2021-2034年中東與非洲大麻二酚市場分析、洞察與預測

  • 國家
    • 南非
    • UAE
    • 其他中東和非洲國家

第11章 競爭矩陣

  • 主要企業採取的商務策略
  • 全球大麻二酚市場收入佔有率排名分析：依主要製造商分類

第12章 公司簡介

  • Medical Marijuana Inc.
  • Cannoid LLC
  • Isodiol International Inc.
  • Folium Biosciences
  • Aurora Cannabis, Inc.
  • Acqua Minerale San Benedetto SpA
  • Pharmahemp doo
  • ENDOCA
  • Elixinol LLC.
  • CV Sciences

第13章 戰略建議

第14章 附錄

Product Code: FBI103215

Growth Factors of cannabidiol (CBD) Market

The global cannabidiol (CBD) market is witnessing unprecedented growth, driven by rising consumer awareness of its health benefits, increased legalization, and growing adoption across multiple industries. According to the latest report by Fortunebusinessinsights.com, the market size was valued at USD 16.52 billion in 2025 and is projected to grow to USD 24.61 billion in 2026, ultimately reaching USD 382.04 billion by 2034, registering a remarkable CAGR of 40.89% during the forecast period of 2026-2034.

Market Drivers and Growth Factors

CBD is primarily extracted from hemp due to its naturally high cannabidiol content, although it can also be derived from marijuana. Unlike tetrahydrocannabinol (THC), CBD is non-psychoactive, offering several therapeutic benefits including anxiety relief, anti-inflammatory properties, seizure prevention, and pain reduction. The surge in demand is further fueled by its incorporation into the pharmaceutical, cosmetics, and food industries.

Manufacturers are increasingly focusing on innovative product formulations to cater to evolving consumer preferences. For instance, British Cannabis acquired Goodbody Botanicals Ltd in February 2024 to expand its CBD-infused wellness and cosmetics portfolio globally. Moreover, the COVID-19 pandemic initially impacted market growth due to lockdowns and reduced food and beverage operations, but post-pandemic recovery is expected to support robust growth.

Market Segmentation

By Source:

The marijuana-derived CBD segment dominated in 2026, expected to account for 56.07% of the market, benefiting from greater availability and legalization in North America and Europe. Hemp-derived CBD is also gaining traction, particularly in health and wellness products.

By Application:

The pharmaceutical sector remains the largest consumer of CBD products due to its therapeutic benefits. In 2026, the pharmaceutical segment is projected to account for 36.9% of the global market, with significant applications in pain relief, neuroprotection, and inflammation management. The food and beverage sector is also increasingly adopting CBD for fortified and health-focused products.

Regional Insights

North America:

The region dominated the global CBD market in 2025 with 47.63% market share, representing USD 7.87 billion, and is projected to reach USD 11.8 billion in 2026. The U.S. market is expected to grow to USD 78.74 billion by 2032, driven by liberalized regulations and growing consumer acceptance. Canada is also witnessing steady growth through legal reforms and product diversification.

Europe:

Europe held 25.52% of the market in 2025, valued at USD 4.22 billion, and is expected to reach USD 6.28 billion in 2026. Key markets include the UK (USD 1.76 billion in 2026) and Germany (USD 1.19 billion in 2026), with growing demand for smoking, vaping, and edible CBD products.

Asia Pacific:

The market in Asia Pacific reached USD 2.88 billion in 2025 (17.47% share) and is projected to grow to USD 4.28 billion in 2026, driven by regulatory changes in countries like China, Japan, India, and Thailand. Thailand legalized medical cannabis and hemp usage, positioning it as a regional growth hub.

South America, Middle East & Africa, and Latin America:

South America is expanding through legal reforms, with Uruguay, Peru, and Colombia leading medicinal cannabis adoption. Middle East & Africa contributed USD 0.65 billion in 2025, with slower growth due to restrictions in UAE and Saudi Arabia, though Lebanon and South Africa show promising developments. Latin America generated USD 0.9 billion in 2025, expected to reach USD 1.32 billion in 2026.

Key Market Trends

1. Health & Fitness: Consumers increasingly prefer CBD-infused products for wellness, anti-inflammatory benefits, and overall health maintenance. BASF SE launched ComfortBD, a certified organic CBD skincare product, targeting red and irritated skin in August 2022.

2. Government Approvals: Regulatory acceptance, particularly by the U.S. FDA, facilitates CBD incorporation in food, pharma, and other applications.

3. Mergers and Acquisitions: Strategic acquisitions like British Cannabis' 2024 acquisition of Goodbody Botanicals Ltd expand product portfolios and market presence.

Major Players

Leading CBD companies focus on product innovation, R&D, and distribution to consolidate market share. Key players include:

  • Medical Marijuana Inc. (California, U.S.)
  • Medterra CBD (California, U.S.)
  • Aurora Cannabis Inc. (Edmonton, Canada)
  • ENDOCA (Chicago, U.S.)
  • Folium Biosciences (Texas, U.S.)

Conclusion

The global cannabidiol market demonstrates enormous growth potential across pharmaceuticals, cosmetics, and food sectors, propelled by regulatory support, rising consumer awareness, and innovative product offerings. With a projected market value of USD 382.04 billion by 2034, CBD is poised to become a mainstream health and wellness commodity globally.

Segmentation By Source

  • Marijuana
  • Hemp

By Application

  • Pharmaceuticals
  • Food and Beverages
  • Pet Care
  • Cosmetics
  • Others

By Region

  • North America (By Source, Application, and By Country)
    • The U.S. (By Source)
    • Canada (By Source)
    • Mexico (By Source)
  • Europe (By Source, Application, and By Country)
    • Russia (By Source)
    • Austria (By Source)
    • Italy (By Source)
    • Germany (By Source)
    • U.K. (By Source)
    • Rest of Europe (Source)
  • Asia Pacific (By Source, Application, and By Country)
    • China (By Source)
    • Australia (By Source)
    • India (By Source)
    • Japan (By Source)
    • Rest of Asia Pacific (By Source)
  • South America (By Source, Application, and By Country)
    • Argentina (By Source)
    • Brazil (By Source)
    • Rest of South America (By Source)
  • The Middle East and Africa (By Source, Application, and By Country)
    • South Africa (By Source)
    • UAE (By Source)
    • Rest of ME&A (By Source)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Emerging Trends

4. Key Insights

  • 4.1. Overview on Cannabis Markets
  • 4.2. Supply Chain and Industry SWOT Analysis
  • 4.3. Global Cannabidiol Regulatory Analysis
  • 4.4. Recent Industry Developments - Policies, Mergers & Acquisitions, and New Product Launches
  • 4.5. Impact of COVID-19
    • 4.5.1. Challenges in Supply Chain
    • 4.5.2. Efforts to Mitigate the Challenges

5. Global Cannabidiol Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Key Findings / Summary
  • 5.2. Market Size Estimates and Forecast
    • 5.2.1. By Source
      • 5.2.1.1. Marijuana
      • 5.2.1.2. Hemp
    • 5.2.2. By Application
      • 5.2.2.1. Food & Beverages
      • 5.2.2.2. Pharmaceuticals
      • 5.2.2.3. Pet Care
      • 5.2.2.4. Cosmetics
      • 5.2.2.5. Others
    • 5.2.3. By Region
      • 5.2.3.1. North America
      • 5.2.3.2. Europe
      • 5.2.3.3. Asia Pacific
      • 5.2.3.4. South America
      • 5.2.3.5. Middle East & Africa

6. North America Cannabidiol Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Key Findings / Summary
  • 6.2. Market Size Estimates and Forecast
    • 6.2.1. By Source
      • 6.2.1.1. Marijuana
      • 6.2.1.2. Hemp
    • 6.2.2. By Application
      • 6.2.2.1. Food & Beverages
      • 6.2.2.2. Pharmaceuticals
      • 6.2.2.3. Pet Care
      • 6.2.2.4. Cosmetics
      • 6.2.2.5. Others
    • 6.2.3. By Country (Value)
      • 6.2.3.1. U.S
        • 6.2.3.1.1. By Source (Value)
          • 6.2.3.1.1.1. Marijuana
          • 6.2.3.1.1.2. Hemp
      • 6.2.3.2. Canada
        • 6.2.3.2.1. By Source (Value)
          • 6.2.3.2.1.1. Marijuana
          • 6.2.3.2.1.2. Hemp

7. Europe Cannabidiol Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Key Findings / Summary
  • 7.2. Market Size Estimates and Forecast
    • 7.2.1. By Source
      • 7.2.1.1. Marijuana
      • 7.2.1.2. Hemp
    • 7.2.2. By Application
      • 7.2.2.1. Food & Beverages
      • 7.2.2.2. Pharmaceuticals
      • 7.2.2.3. Pet Care
      • 7.2.2.4. Cosmetics
      • 7.2.2.5. Others
    • 7.2.3. By Country (Value)
      • 7.2.3.1. Russia
        • 7.2.3.1.1. By Source (Value)
          • 7.2.3.1.1.1. Marijuana
          • 7.2.3.1.1.2. Hemp
      • 7.2.3.2. Austria
        • 7.2.3.2.1. By Source (Value)
          • 7.2.3.2.1.1. Marijuana
          • 7.2.3.2.1.2. Hemp
      • 7.2.3.3. Italy
        • 7.2.3.3.1. By Source (Value)
          • 7.2.3.3.1.1. Marijuana
          • 7.2.3.3.1.2. Hemp
      • 7.2.3.4. Germany
        • 7.2.3.4.1. By Source (Value)
          • 7.2.3.4.1.1. Marijuana
          • 7.2.3.4.1.2. Hemp
      • 7.2.3.5. U.K.
        • 7.2.3.5.1. By Source (Value)
          • 7.2.3.5.1.1. Marijuana
          • 7.2.3.5.1.2. Hemp
      • 7.2.3.6. Rest of Europe
        • 7.2.3.6.1. By Source (Value)
          • 7.2.3.6.1.1. Marijuana
          • 7.2.3.6.1.2. Hemp

8. Asia Pacific Cannabidiol Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Key Findings / Summary
  • 8.2. Market Size Estimates and Forecast
    • 8.2.1. By Source
      • 8.2.1.1. Marijuana
      • 8.2.1.2. Hemp
    • 8.2.2. By Application
      • 8.2.2.1. Food & Beverages
      • 8.2.2.2. Pharmaceuticals
      • 8.2.2.3. Pet Care
      • 8.2.2.4. Cosmetics
      • 8.2.2.5. Others
    • 8.2.3. By Country (Value)
      • 8.2.3.1. China
        • 8.2.3.1.1. By Source (Value)
          • 8.2.3.1.1.1. Marijuana
          • 8.2.3.1.1.2. Hemp
      • 8.2.3.2. Australia
        • 8.2.3.2.1. By Source (Value)
          • 8.2.3.2.1.1. Marijuana
          • 8.2.3.2.1.2. Hemp
      • 8.2.3.3. India
        • 8.2.3.3.1. By Source (Value)
          • 8.2.3.3.1.1. Marijuana
          • 8.2.3.3.1.2. Hemp
      • 8.2.3.4. Japan
        • 8.2.3.4.1. By Source (Value)
          • 8.2.3.4.1.1. Marijuana
          • 8.2.3.4.1.2. Hemp
      • 8.2.3.5. Rest of APAC
        • 8.2.3.5.1. By Source (Value)
          • 8.2.3.5.1.1. Marijuana
          • 8.2.3.5.1.2. Hemp

9. South America Cannabidiol Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Key Findings / Summary
  • 9.2. Market Size Estimates and Forecast
    • 9.2.1. By Source
      • 9.2.1.1. Marijuana
      • 9.2.1.2. Hemp
    • 9.2.2. By Application
      • 9.2.2.1. Food & Beverages
      • 9.2.2.2. Pharmaceuticals
      • 9.2.2.3. Pet Care
      • 9.2.2.4. Cosmetics
      • 9.2.2.5. Others
    • 9.2.3. By Country (Value)
      • 9.2.3.1. Argentina
        • 9.2.3.1.1. By Source (Value)
          • 9.2.3.1.1.1. Marijuana
          • 9.2.3.1.1.2. Hemp
      • 9.2.3.2. Brazil
        • 9.2.3.2.1. By Source (Value)
          • 9.2.3.2.1.1. Marijuana
          • 9.2.3.2.1.2. Hemp
      • 9.2.3.3. Rest of South America
        • 9.2.3.3.1. By Source (Value)
          • 9.2.3.3.1.1. Marijuana
          • 9.2.3.3.1.2. Hemp

10. Middle East & Africa Cannabidiol Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Key Findings / Summary
  • 10.2. Market Size Estimates and Forecast
    • 10.2.1. By Source
      • 10.2.1.1. Marijuana
      • 10.2.1.2. Hemp
    • 10.2.2. By Application
      • 10.2.2.1. Food & Beverages
      • 10.2.2.2. Pharmaceuticals
      • 10.2.2.3. Pet Care
      • 10.2.2.4. Cosmetics
      • 10.2.2.5. Others
    • 10.2.3. By Country (Value)
      • 10.2.3.1. South Africa
        • 10.2.3.1.1. By Source (Value)
          • 10.2.3.1.1.1. Marijuana
          • 10.2.3.1.1.2. Hemp
      • 10.2.3.2. UAE
        • 10.2.3.2.1. By Source (Value)
          • 10.2.3.2.1.1. Marijuana
          • 10.2.3.2.1.2. Hemp
      • 10.2.3.3. Rest of ME&A
        • 10.2.3.3.1. By Source (Value)
          • 10.2.3.3.1.1. Marijuana

11. Competitive Matrix

  • 11.1. Business Strategies Adopted by Leading Players
  • 11.2. Global Cannabidiol Market Revenue Share/Ranking Analysis, By Key Manufacturer

12. Company Profiles

  • 12.1. Medical Marijuana Inc.
    • 12.1.1. Overview
    • 12.1.2. Description
    • 12.1.3. Source Portfolio
    • 12.1.4. Financials (Data as available in public domain and/or on paid databases)
    • 12.1.5. Recent Developments
  • 12.2. Cannoid LLC
    • 12.2.1. Overview
    • 12.2.2. Description
    • 12.2.3. Source Portfolio
    • 12.2.4. Financials (Data as available in public domain and/or on paid databases)
    • 12.2.5. Recent Developments
  • 12.3. Isodiol International Inc.
    • 12.3.1. Overview
    • 12.3.2. Description
    • 12.3.3. Source Portfolio
    • 12.3.4. Financials (Data as available in public domain and/or on paid databases)
    • 12.3.5. Recent Developments
  • 12.4. Folium Biosciences
    • 12.4.1. Overview
    • 12.4.2. Description
    • 12.4.3. Source Portfolio
    • 12.4.4. Financials (Data as available in public domain and/or on paid databases)
    • 12.4.5. Recent Developments
  • 12.5. Aurora Cannabis, Inc.
    • 12.5.1. Overview
    • 12.5.2. Description
    • 12.5.3. Source Portfolio
    • 12.5.4. Financials (Data as available in public domain and/or on paid databases)
    • 12.5.5. Recent Developments
  • 12.6. Acqua Minerale San Benedetto SpA
    • 12.6.1. Overview
    • 12.6.2. Description
    • 12.6.3. Source Portfolio
    • 12.6.4. Financials (Data as available in public domain and/or on paid databases)
    • 12.6.5. Recent Developments
  • 12.7. Pharmahemp d.o.o
    • 12.7.1. Overview
    • 12.7.2. Description
    • 12.7.3. Source Portfolio
    • 12.7.4. Financials (Data as available in public domain and/or on paid databases)
    • 12.7.5. Recent Developments
  • 12.8. ENDOCA
    • 12.8.1. Overview
    • 12.8.2. Description
    • 12.8.3. Source Portfolio
    • 12.8.4. Financials (Data as available in public domain and/or on paid databases)
    • 12.8.5. Recent Developments
  • 12.9. Elixinol LLC.
    • 12.9.1. Overview
    • 12.9.2. Description
    • 12.9.3. Source Portfolio
    • 12.9.4. Financials (Data as available in public domain and/or on paid databases)
    • 12.9.5. Recent Developments
  • 12.10. CV Sciences
    • 12.10.1. Overview
    • 12.10.2. Description
    • 12.10.3. Source Portfolio
    • 12.10.4. Financials (Data as available in public domain and/or on paid databases)
    • 12.10.5. Recent Developments

13. Strategic Recommendations

14. Appendix

List of Tables

  • Table 1: Global Cannabidiol Market Revenue (USD Mn) Forecast, 2021-2034
  • Table 2: Global Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034
  • Table 3: Global Cannabidiol Market Revenue (USD Mn) Forecast, by Application, 2021-2034
  • Table 4: Global Cannabidiol Market Revenue (USD Mn) Forecast, by Region, 2021-2034
  • Table 5: North America Cannabidiol Market Revenue (USD Mn) Forecast, 2021-2034
  • Table 6: North America Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034
  • Table 7: North America Cannabidiol Market Revenue (USD Mn) Forecast, by Application, 2021-2034
  • Table 8: North America Cannabidiol Market Revenue (USD Mn) Forecast, by Country, 2021-2034
  • Table 9: U.S. Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034
  • Table 10: Canada Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034
  • Table 11: Europe Cannabidiol Market Revenue (USD Mn) Forecast, 2021-2034
  • Table 12: Europe Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034
  • Table 13: Europe Cannabidiol Market Revenue (USD Mn) Forecast, by Application, 2021-2034
  • Table 14: Europe Cannabidiol Market Revenue (USD Mn) Forecast, by Country, 2021-2034
  • Table 15: Russia Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034
  • Table 16: Austria Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034
  • Table 17: Italy Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034
  • Table 18: Germany Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034
  • Table 19: U.K. Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034
  • Table 20: Rest of Europe Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034
  • Table 21: Asia Pacific Cannabidiol Market Revenue (USD Mn) Forecast, 2021-2034
  • Table 22: Asia Pacific Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034
  • Table 23: Asia Pacific Cannabidiol Market Revenue (USD Mn) Forecast, by Application, 2021-2034
  • Table 24: Asia Pacific Cannabidiol Market Revenue (USD Mn) Forecast, by Country, 2021-2034
  • Table 25: China Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034
  • Table 26: Australia Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034
  • Table 27: India Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034
  • Table 28: Japan Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034
  • Table 29: Rest of Asia Pacific Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034
  • Table 30: South America Cannabidiol Market Revenue (USD Mn) Forecast, 2021-2034
  • Table 31: South America Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034
  • Table 32: South America Cannabidiol Market Revenue (USD Mn) Forecast, by Application, 2021-2034
  • Table 33: South America Cannabidiol Market Revenue (USD Mn) Forecast, by Country, 2021-2034
  • Table 34: Argentina Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034
  • Table 35: Brazil Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034
  • Table 36: Rest of South America Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034
  • Table 37: Middle East & Africa Cannabidiol Market Revenue (USD Mn) Forecast, 2021-2034
  • Table 38: Middle East & Africa Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034
  • Table 39: Middle East & Africa Cannabidiol Market Revenue (USD Mn) Forecast, by Application, 2021-2034
  • Table 40: Middle East & Africa Cannabidiol Market Revenue (USD Mn) Forecast, by Country, 2021-2034
  • Table 41: South Africa Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034
  • Table 42: UAE Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034
  • Table 43: Rest of Middle East & Africa Cannabidiol Market Revenue (USD Mn) Forecast, by Source, 2021-2034

List of Figures

  • Figure 1: Global Cannabidiol Market Revenue (USD Mn) Breakdown by Source, 2025 & 2034
  • Figure 2: Global Cannabidiol Market Revenue (USD Mn) Breakdown by Application, 2025 & 2034
  • Figure 3: Global Cannabidiol Market Revenue (USD Mn) Breakdown by Region, 2025 & 2034
  • Figure 4: Global Cannabidiol Market Share (%) by Source, 2025 & 2028
  • Figure 5: Global Cannabidiol Market Share (%) by Application, 2025 & 2028
  • Figure 6: Global Cannabidiol Market Share (%) by Region, 2025 & 2028
  • Figure 7: North America Cannabidiol Market Value (USD Mn) by Source, 2025 & 2034
  • Figure 8: North America Cannabidiol Market Value Share (%) by Source, 2025
  • Figure 9: North America Cannabidiol Market Value (USD Mn) by Application, 2025 & 2034
  • Figure 10: North America Cannabidiol Market Value Share (%) by Application, 2025
  • Figure 11: North America Cannabidiol Market Value (USD Mn) by Country, 2025 & 2034
  • Figure 12: North America Cannabidiol Market Value Share (%) by Country, 2025
  • Figure 13: U.S. Cannabidiol Market Value (USD Mn) by Source, 2025 & 2034
  • Figure 14: Canada Cannabidiol Market Value (USD Mn) by Source, 2025 & 2034
  • Figure 15: Europe Cannabidiol Market Value (USD Mn) by Source, 2025 & 2034
  • Figure 16: Europe Cannabidiol Market Value Share (%) by Source, 2025
  • Figure 17: Europe Cannabidiol Market Value (USD Mn) by Application, 2025 & 2034
  • Figure 18: Europe Cannabidiol Market Value Share (%) by Application, 2025
  • Figure 19: Europe Cannabidiol Market Value (USD Mn) by Country, 2025 & 2034
  • Figure 20: Europe Cannabidiol Market Value Share (%) by Country, 2025
  • Figure 21: Russia Cannabidiol Market Value (USD Mn) by Source, 2025 & 2034
  • Figure 22: Austria Cannabidiol Market Value (USD Mn) by Source, 2025 & 2034
  • Figure 23: Italy Cannabidiol Market Value (USD Mn) by Source, 2025 & 2034
  • Figure 24: Germany Cannabidiol Market Value (USD Mn) by Source, 2025 & 2034
  • Figure 25: U.K. Cannabidiol Market Value (USD Mn) by Source, 2025 & 2034
  • Figure 26: Rest of Europe Cannabidiol Market Value (USD Mn) by Source, 2025 & 2034
  • Figure 27: Asia Pacific Cannabidiol Market Value (USD Mn) by Source, 2025 & 2034
  • Figure 28: Asia Pacific Cannabidiol Market Value Share (%) by Source, 2025
  • Figure 29: Asia Pacific Cannabidiol Market Value (USD Mn) by Application, 2025 & 2034
  • Figure 30: Asia Pacific Cannabidiol Market Value Share (%) by Application, 2025
  • Figure 31: Asia Pacific Cannabidiol Market Value (USD Mn) by Country, 2025 & 2034
  • Figure 32: Asia Pacific Cannabidiol Market Value Share (%) by Country, 2025
  • Figure 33: China Cannabidiol Market Value (USD Mn) by Source, 2025 & 2034
  • Figure 34: Australia Cannabidiol Market Value (USD Mn) by Source, 2025 & 2034
  • Figure 35: India Cannabidiol Market Value (USD Mn) by Source, 2025 & 2034
  • Figure 36: Japan Cannabidiol Market Value (USD Mn) by Source, 2025 & 2034
  • Figure 37: Rest of Asia Pacific Cannabidiol Market Value (USD Mn) by Source, 2025 & 2034
  • Figure 38: South America Cannabidiol Market Value (USD Mn) by Source, 2025 & 2034
  • Figure 39: South America Cannabidiol Market Value Share (%) by Source, 2025
  • Figure 40: South America Cannabidiol Market Value (USD Mn) by Application, 2025 & 2034
  • Figure 41: South America Cannabidiol Market Value Share (%) by Application, 2025
  • Figure 42: South America Cannabidiol Market Value (USD Mn) by Country, 2025 & 2034
  • Figure 43: South America Cannabidiol Market Value Share (%) by Country, 2025
  • Figure 44: Brazil Cannabidiol Market Value (USD Mn) by Source, 2025 & 2034
  • Figure 45: Argentina Cannabidiol Market Value (USD Mn) by Source, 2025 & 2034
  • Figure 46: Rest of South America Cannabidiol Market Value (USD Mn) by Source, 2025 & 2034
  • Figure 47: Middle East & Africa Cannabidiol Market Value (USD Mn) by Source, 2025 & 2034
  • Figure 48: Middle East & Africa Cannabidiol Market Value Share (%) by Source, 2025
  • Figure 49: Middle East & Africa Cannabidiol Market Value (USD Mn) by Application, 2025 & 2034
  • Figure 50: Middle East & Africa Cannabidiol Market Value Share (%) by Application, 2025
  • Figure 51: Middle East & Africa Cannabidiol Market Value (USD Mn) by Country, 2025 & 2034
  • Figure 52: Middle East & Africa Cannabidiol Market Value Share (%) by Country, 2025
  • Figure 53: South Africa Cannabidiol Market Value (USD Mn) by Source, 2025 & 2034
  • Figure 54: UAE Cannabidiol Market Value (USD Mn) by Source, 2025 & 2034
  • Figure 55: Rest of Middle East & Africa Cannabidiol Market Value (USD Mn) by Source, 2025 & 2034
  • Figure 56: Global Cannabidiol Market Revenue (%) Share Analysis by Key Players, 2025